JPMorgan Chase & Co. - Net Worth and Insider Trading
JPMorgan Chase & Co. Net Worth
The estimated net worth of JPMorgan Chase & Co. is at least $989 Million dollars as of 2025-05-26. JPMorgan Chase & Co. is the 2201 Interest of corporation controlled by you of Ascentage Pharma Group International and owns about 19,899,031 shares of Ascentage Pharma Group International (HKSE:06855) stock worth over $989 Million. Details can be seen in JPMorgan Chase & Co.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that JPMorgan Chase & Co. has not made any transactions after 2025-02-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of JPMorgan Chase & Co.
JPMorgan Chase & Co. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, JPMorgan Chase & Co. owns 1 companies in total, including Ascentage Pharma Group International (HKSE:06855) .
Click here to see the complete history of JPMorgan Chase & Co.’s form 4 insider trades.
Insider Ownership Summary of JPMorgan Chase & Co.
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:06855 | Ascentage Pharma Group International | 2025-02-11 | 2201 Interest of corporation controlled by you |
JPMorgan Chase & Co. Latest Holdings Summary
JPMorgan Chase & Co. currently owns a total of 1 stock. JPMorgan Chase & Co. owns 19,899,031 shares of Ascentage Pharma Group International (HKSE:06855) as of February 6, 2025, with a value of $989 Million.
Latest Holdings of JPMorgan Chase & Co.
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:06855 | Ascentage Pharma Group International | 2025-02-06 | 19,899,031 | 49.70 | 988,981,841 |
Holding Weightings of JPMorgan Chase & Co.
JPMorgan Chase & Co. Form 4 Trading Tracker
According to the SEC Form 4 filings, JPMorgan Chase & Co. has made a total of 10 transactions in Ascentage Pharma Group International (HKSE:06855) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Ascentage Pharma Group International is the sale of 1,738,800 shares on February 6, 2025, which brought JPMorgan Chase & Co. around $63 Million.
Insider Trading History of JPMorgan Chase & Co.
- 1
JPMorgan Chase & Co. Trading Performance
GuruFocus tracks the stock performance after each of JPMorgan Chase & Co.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by JPMorgan Chase & Co. is 4.2%. GuruFocus also compares JPMorgan Chase & Co.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by JPMorgan Chase & Co. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how JPMorgan Chase & Co.'s insider trading performs compared to the benchmark.
Performance of JPMorgan Chase & Co.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.61 | | | | | |
| Relative Return to S&P 500(%) | 3.99 | | | | | |
JPMorgan Chase & Co. Ownership Network
Ownership Network List of JPMorgan Chase & Co.
Ownership Network Relation of JPMorgan Chase & Co.
JPMorgan Chase & Co. Owned Company Details
What does Ascentage Pharma Group International do?
Who are the key executives at Ascentage Pharma Group International?
JPMorgan Chase & Co. is the 2201 Interest of corporation controlled by you of Ascentage Pharma Group International. Other key executives at Ascentage Pharma Group International include 2201 Interest of corporation controlled by you Takeda Pharmaceuticals Company Limited , 2101 Beneficial owner Takeda Pharmaceuticals International AG , and Ascentage Limited .
Ascentage Pharma Group International (HKSE:06855) Insider Trades Summary
Over the past 18 months, JPMorgan Chase & Co. made 8 insider transaction in Ascentage Pharma Group International (HKSE:06855) with a net sale of 0. Other recent insider transactions involving Ascentage Pharma Group International (HKSE:06855) include a net purchase of 24,307,322 shares made by Takeda Pharmaceuticals International AG , a net purchase of 24,307,322 shares made by Takeda Pharmaceuticals Company Limited ,
In summary, during the past 3 months, insiders sold 0 shares of Ascentage Pharma Group International (HKSE:06855) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ascentage Pharma Group International (HKSE:06855) were sold and 48,614,644 shares were bought by its insiders, resulting in a net purchase of 48,614,644 shares.
Ascentage Pharma Group International (HKSE:06855)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ascentage Pharma Group International Insider Transactions
JPMorgan Chase & Co. Mailing Address
Above is the net worth, insider trading, and ownership report for JPMorgan Chase & Co.. Currently GuruFocus does not have mailing address information for JPMorgan Chase & Co..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
